Keyphrases
During Pregnancy
100%
Antibody Level
100%
Substance Exposure
100%
Perfluoroalkyl Substances
100%
SARS-CoV-2 IgG Antibody
100%
Perfluorohexanoic Acid (PFHxA)
27%
Maternal Plasma
27%
Mixture Effects
27%
COVID-19
18%
Maternal Age
18%
IgG Titer
18%
Anti-SARS-CoV-2 IgG
18%
Substance Concentration
18%
Maternal IgG
18%
Anti-spike IgG Antibody
18%
Environmental Factors
9%
Gestational Age
9%
New York City
9%
SARS-CoV-2 Infection
9%
Multivariable
9%
Statistical Significance
9%
Immune Regulation
9%
Humoral Immune Response
9%
Race-ethnicity
9%
Ethnically Diverse
9%
Linear Regression
9%
IgG Antibody
9%
Adverse Pregnancy Outcomes
9%
Immune Function
9%
Health Effects
9%
COVID-19 Pandemic
9%
Correlation Regression
9%
COVID-19 Vaccination
9%
Spearman Correlation
9%
Birth Cohort
9%
Insurance
9%
SARS-CoV-2 Antibodies
9%
Maternal Race
9%
COVID-19 Severity
9%
COVID-19 Symptoms
9%
Pregnancy Cohort
9%
Pre-pregnancy BMI
9%
Weighted Quantile Sum (WQS) Regression
9%
Weighted Quantile Sum
9%
Infections In Pregnancy
9%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
9%
Short Chain
9%
Man-made
9%
Neonatal Immune System
9%
Vaccination Status
9%
Immunotoxicity
9%
Altered States
9%
Generation C
9%
IgG Antibody Titer
9%
Persistent Organic Compounds
9%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Immunoglobulin G Antibody
100%
Maternal Plasma
42%
COVID-19
28%
Immunity
28%
Maternal Age
28%
Infection
14%
Linear Regression Analysis
14%
Body Mass Index
14%
Population Research
14%
Immune Response
14%
Humoral Immunity
14%
Obstetrics
14%
Immunosuppressant
14%
Environmental Factor
14%
Enzyme Linked Immunosorbent Assay
14%
COVID-19 Vaccination
14%
Tandem Mass Spectrometry
14%
Ultra Performance Liquid Chromatography
14%
Immunotoxicity
14%
Gestational Age
14%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Immunoglobulin G Antibody
100%
COVID-19
42%
Titer
42%
Maternal Plasma
42%
Spike
28%
Immunity
28%
Maternal Age
28%
Blood Plasma
14%
Immune Response
14%
Humoral Immunity
14%
Population Research
14%
ELISA
14%
Tandem Mass Spectrometry
14%
Immunosuppressant
14%
Ultra High Performance Liquid Chromatography
14%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Immunoglobulin G Antibody
100%
Immunosuppressive Agent
14%
Infection
14%
Population Study
14%
Enzyme-Linked Immunosorbent Assay
14%
Ultra High Performance Liquid Chromatography
14%
Immunotoxicity
14%